Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum.
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
- Want More Sustainable Biopharma Packaging? Try These Levers
- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
- Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
- How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
- The EU Overhauls Pharma Laws: What You Need To Know
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
For Greater Transparency And Efficiency
Paper-heavy production can slow decisions and limit flexibility. See how IT/OT integration connects shop-floor and enterprise data to support real-time visibility and more resilient operations.
-
Sensitive RNA Fluorescent Quantitation With An RNA Assay Kit
Accurate nucleic acid quantification is vital for applications like PCR and NGS. Discover an RNA Assay Kit that offers precise RNA measurement to enhance reliability and performance in downstream assays.
-
Optimize Your Approach To mAb Development
To meet the growing demand for mAbs and their variants, it is important to leverage opportunities for optimization as well as work with suppliers that have the resources to help your workflow thrive.
-
Efficient Monitoring Of Escherichia Coli Feeding Strategies
Consistent, contamination-free sampling is critical for reliable bioprocess data. Automation enables frequent, hands-free collection, improving efficiency and insight while reducing manual workload.
-
Rapid And Sensitive Detection Of Replication-Competent Lentivirus (RCL)
See how a rapid digital PCR workflow enables reliable detection of trace RCL levels while maintaining strong performance in complex samples, which support more confident decisions in manufacturing.
-
Delivering Complex Oncology Trials At Scale
Parexel delivered two complex, global Phase III prostate cancer trials by aligning site selection, logistics, imaging workflows, and RAM regulatory expertise—achieving faster enrollment and on‑time execution.
-
Using dSEC-7 Column For Separation And Length Determination Of mRNA
mRNA analysis depends on methods that can separate broad size ranges. Learn how retention time can help estimate transcript length and complement capillary electrophoresis workflows.
-
In Vivo RNA Tuning For Liver Gene Editing Efficiency
RNA sequence and guide modifications, delivery platform design, and dose optimization all contribute to improved gene editing outcomes, which offers a clearer path toward safer, more potent, and scalable mRNA-based therapeutics.
-
Meeting Critical Deadlines: Custom Assemblies For Viral Vector Manufacturing
Meeting tight production timelines requires planning and supply chain resilience. Learn how manufacturing coordination supported viral vector production and delivery under pressure.
-
Redefining Biomanufacturing For Personalized Cancer Vaccines
Personalized cancer vaccines need fast, flexible manufacturing. Cell‑free synthetic DNA enables rapid, small‑batch mRNA production, supporting individualized therapies beyond plasmid‑based limits.
NEWSLETTER ARCHIVE
- 11.10.26 -- Implementing AI And Digital Twins In Bioprocessing With Will Olughu, Ph.D.
- 11.10.26 -- How To Stand Up A Hospital-Based CAR-T Manufacturing Network
- 11.09.26 -- Is Your Single-Use Process Built To Perform?
- 11.09.26 -- Building A Fill-Finish Strategy That Lasts
- 11.09.26 -- Why You Should Measure Comparability Debt Before Ever Starting A Study
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

